A descriptive study of trends in opioid and associated analgesic prescribing over time, particularly among cancer patients.

Ended Purchase Order Awarded Last action

Contract number
75N91019P00220
Awardee
Awarding agency
Obligated
$20,000

Award facts

Opportunity
  • 75N01019Q00036 Solicitation number
Contract value 100% obligated
$20,000.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
541714 Research and Development in Biotechnology (except Nanobiotechnology)
PSC
Q301 Reference Laboratory Testing
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Raleigh, NC 27612, USA

Award details come from SAM.gov/FPDS.

About this award

Written by GovTribe AI ·

The National Cancer Institute awarded a purchase order to Pharmaceutical Research Associates Inc. for $20,000.00 on April 24, 2019, to conduct a descriptive study of trends in opioid and associated analgesic prescribing over time, particularly among cancer patients. Performance is located in Raleigh, North Carolina. The contract carries a firm fixed price and no set-aside designation. Work is scheduled for completion by October 24, 2019.

Quick answers

Who was awarded contract 75N91019P00220?

75N91019P00220 was awarded to Pharmaceutical Research Associates Inc. by National Cancer Institute (National Institutes of Health) on April 24, 2019.

How much is contract 75N91019P00220 worth?

The government has obligated $20,000 on 75N91019P00220.

Was contract 75N91019P00220 competed?

The extent of competition for 75N91019P00220 was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login